» Articles » PMID: 26342204

Effectiveness of Revascularization of the Ulcerated Foot in Patients with Diabetes and Peripheral Artery Disease: a Systematic Review

Overview
Specialty Endocrinology
Date 2015 Sep 6
PMID 26342204
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

Symptoms or signs of peripheral artery disease (PAD) can be observed in up to 50% of the patients with a diabetic foot ulcer and is a risk factor for poor healing and amputation. In 2012, a multidisciplinary working group of the International Working Group on the Diabetic Foot published a systematic review on the effectiveness of revascularization of the ulcerated foot in patients with diabetes and PAD. This publication is an update of this review and now includes the results of a systematic search for therapies to revascularize the ulcerated foot in patients with diabetes and PAD from 1980 to June 2014. Only clinically relevant outcomes were assessed. The research conformed to the Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines, and Scottish Intercollegiate Guidelines Network methodological scores were assigned. A total of 56 articles were eligible for full-text review. There were no randomized controlled trials, but there were four nonrandomized studies with a control group. The major outcomes following endovascular or open bypass surgery were broadly similar among the studies. Following open surgery, the 1-year limb salvage rates were a median of 85% (interquartile range of 80-90%), and following endovascular revascularization, these rates were 78% (70-89%). At 1-year follow-up, 60% or more of ulcers had healed following revascularization with either open bypass surgery or endovascular techniques. Studies appeared to demonstrate improved rates of limb salvage associated with revascularization compared with the results of conservatively treated patients in the literature. There were insufficient data to recommend one method of revascularization over another. There is a real need for standardized reporting of baseline demographic data, severity of disease and outcome reporting in this group of patients.

Citing Articles

One-Year Analysis of Autologous Peripheral Blood Mononuclear Cells as Adjuvant Therapy in Treatment of Diabetic Revascularizable Patients Affected by Chronic Limb-Threatening Ischemia: Real-World Data from Italian Registry ROTARI.

Furgiuele S, Cappello E, Ruggeri M, Camilli D, Palasciano G, Guerrieri M J Clin Med. 2024; 13(17).

PMID: 39274487 PMC: 11396002. DOI: 10.3390/jcm13175275.


Performance of risk prediction models for diabetic foot ulcer: a meta-analysis.

Guo P, Tu Y, Liu R, Gao Z, Du M, Fu Y PeerJ. 2024; 12:e17770.

PMID: 39035162 PMC: 11260075. DOI: 10.7717/peerj.17770.


Brazilian Society of Angiology and Vascular Surgery 2023 guidelines on the diabetic foot.

Duarte E, Lopes C, Gaio D, Mariuba J, Cerqueira L, Manhanelli M J Vasc Bras. 2024; 23:e20230087.

PMID: 38803655 PMC: 11129855. DOI: 10.1590/1677-5449.202300872.


Assessing the Prevalence Rate of Gangrene Among Patients With Peripheral Vascular Disease in a Tertiary Care Hospital in Central India.

Bhargava A, Mahakalkar C, Kshirsagar S, Dhole S Cureus. 2024; 16(3):e57038.

PMID: 38681301 PMC: 11048734. DOI: 10.7759/cureus.57038.


[National expert consensus on the diagnosis and surgical treatment of diabetic foot ulcers complicated with lower extremity vasculopathy (2024 version)].

Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi. 2024; 40(3):206-220.

PMID: 38548391 PMC: 11630131. DOI: 10.3760/cma.j.cn501225-20231122-00202.